Cargando…

The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel

Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Ivan, Schiano Moriello, Nicola, Hopstaken, Rogier, Llor, Carl, Melbye, Hasse, Senn, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857389/
https://www.ncbi.nlm.nih.gov/pubmed/36673130
http://dx.doi.org/10.3390/diagnostics13020320
_version_ 1784873857393360896
author Gentile, Ivan
Schiano Moriello, Nicola
Hopstaken, Rogier
Llor, Carl
Melbye, Hasse
Senn, Oliver
author_facet Gentile, Ivan
Schiano Moriello, Nicola
Hopstaken, Rogier
Llor, Carl
Melbye, Hasse
Senn, Oliver
author_sort Gentile, Ivan
collection PubMed
description Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common indications for their prescription. An expert panel conducted an extensive report on C-reactive protein point-of-care (CRP POC) testing in the evaluation of LRTIs and its usefulness to limit antibiotic prescriptions. The expert panel stated that CRP POC testing is a potentially useful tool to limit antibiotic prescriptions for LRTI in a community setting. CRP POC must be used in conjunction with other strategies such as improved communication skills and the use of other molecular POC testing. Potential barriers to the adoption of CRP POC testing are financial and logistical issues. Moreover, the efficacy in limiting antibiotic prescriptions could be hampered by the fact that, in some countries, patients may gain access to antibiotics even without a prescription. Through the realization of a better reimbursement structure, the inclusion in standardized procedures in local guidelines, and better patient education, CRP point-of-care testing can represent a cornerstone in the fight against antimicrobial resistance.
format Online
Article
Text
id pubmed-9857389
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98573892023-01-21 The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel Gentile, Ivan Schiano Moriello, Nicola Hopstaken, Rogier Llor, Carl Melbye, Hasse Senn, Oliver Diagnostics (Basel) Article Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common indications for their prescription. An expert panel conducted an extensive report on C-reactive protein point-of-care (CRP POC) testing in the evaluation of LRTIs and its usefulness to limit antibiotic prescriptions. The expert panel stated that CRP POC testing is a potentially useful tool to limit antibiotic prescriptions for LRTI in a community setting. CRP POC must be used in conjunction with other strategies such as improved communication skills and the use of other molecular POC testing. Potential barriers to the adoption of CRP POC testing are financial and logistical issues. Moreover, the efficacy in limiting antibiotic prescriptions could be hampered by the fact that, in some countries, patients may gain access to antibiotics even without a prescription. Through the realization of a better reimbursement structure, the inclusion in standardized procedures in local guidelines, and better patient education, CRP point-of-care testing can represent a cornerstone in the fight against antimicrobial resistance. MDPI 2023-01-15 /pmc/articles/PMC9857389/ /pubmed/36673130 http://dx.doi.org/10.3390/diagnostics13020320 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gentile, Ivan
Schiano Moriello, Nicola
Hopstaken, Rogier
Llor, Carl
Melbye, Hasse
Senn, Oliver
The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title_full The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title_fullStr The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title_full_unstemmed The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title_short The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
title_sort role of crp poc testing in the fight against antibiotic overuse in european primary care: recommendations from a european expert panel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857389/
https://www.ncbi.nlm.nih.gov/pubmed/36673130
http://dx.doi.org/10.3390/diagnostics13020320
work_keys_str_mv AT gentileivan theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT schianomoriellonicola theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT hopstakenrogier theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT llorcarl theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT melbyehasse theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT sennoliver theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT gentileivan roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT schianomoriellonicola roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT hopstakenrogier roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT llorcarl roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT melbyehasse roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel
AT sennoliver roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel